Fluocinolone Acetonide Ear Drops Recalled Due to Failed Specification
Glenmark Pharmaceuticals is recalling Fluocinolone Acetonide Oil 0.01% ear drops due to failed excipient specifications. The affected lots nationwide do not meet required quality standards for isopropyl alcohol content.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall due to failed pharmaceutical excipient quality specifications. With no reported adverse events or illnesses, this represents a precautionary quality control issue rather than an identified serious health hazard.
Plain-English summary
Glenmark Pharmaceuticals Inc., USA, is recalling Fluocinolone Acetonide Oil 0.01% (Ear Drops) because the product failed excipient specifications. Specifically, the isopropyl alcohol content in the affected lots did not meet required quality standards.
The recall affects 38,496 bottles distributed nationwide. The affected lot numbers are 05220346 and 05220369 (expiring 1/31/2024), 05220582 (expiring 2/29/2024), and 05220861 (expiring 3/31/2024). The product is manufactured by Glenmark Pharmaceuticals Ltd. in India and distributed by Glenmark Pharmaceuticals Inc., USA, under NDC 68462-185-56.
Patients using affected medication should contact their healthcare provider. Healthcare providers and distributors should check their inventories against the lot numbers and contact their supplier for instructions regarding return or replacement of affected products.
The recalled product
- Product
- FLUOCINOLONE ACETONIDE (FLUOCINOLONE ACETONIDE)
- Brand
- FLUOCINOLONE ACETONIDE
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Category
- Drug — Prescription Drug
- Hazard
- specification-failure
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot #: 05220346
- 05220369 Exp 1/31/ 2024
- 05220582
- Exp 2/29/2024
- 05220861 Exp 3/31/2024
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- ModerateTopCare Earwax Removal Kit Recalled for Subpotent Drug Content
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22
- ModerateCAREone Earwax Removal Drops Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22